Logo image of BYL.CA

BAYLIN TECHNOLOGIES INC (BYL.CA) Stock Fundamental Analysis

TSX:BYL - Toronto Stock Exchange - CA0728191051 - Common Stock - Currency: CAD

0.3  -0.02 (-4.76%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BYL. BYL was compared to 15 industry peers in the Electronic Equipment, Instruments & Components industry. BYL has a bad profitability rating. Also its financial health evaluation is rather negative. BYL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BYL had negative earnings in the past year.
BYL had a negative operating cash flow in the past year.
BYL had negative earnings in each of the past 5 years.
In the past 5 years BYL reported 4 times negative operating cash flow.
BYL.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

BYL has a Return On Assets of -35.02%. This is in the lower half of the industry: BYL underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROIC N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL.CA Yearly ROA, ROE, ROICBYL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10K 20K 30K

1.3 Margins

BYL has a Gross Margin of 40.42%. This is in the lower half of the industry: BYL underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of BYL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for BYL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
BYL.CA Yearly Profit, Operating, Gross MarginsBYL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

BYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BYL has more shares outstanding
Compared to 5 years ago, BYL has more shares outstanding
The debt/assets ratio for BYL has been reduced compared to a year ago.
BYL.CA Yearly Shares OutstandingBYL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BYL.CA Yearly Total Debt VS Total AssetsBYL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

BYL has an Altman-Z score of -3.04. This is a bad value and indicates that BYL is not financially healthy and even has some risk of bankruptcy.
BYL has a Altman-Z score of -3.04. This is amonst the worse of the industry: BYL underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.04
ROIC/WACCN/A
WACC8.78%
BYL.CA Yearly LT Debt VS Equity VS FCFBYL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.86 indicates that BYL may have some problems paying its short term obligations.
With a Current ratio value of 0.86, BYL is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.55 indicates that BYL may have some problems paying its short term obligations.
BYL has a Quick ratio of 0.55. This is in the lower half of the industry: BYL underperforms 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.55
BYL.CA Yearly Current Assets VS Current LiabilitesBYL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
The Revenue has grown by 30.98% in the past year. This is a very strong growth!
Measured over the past years, BYL shows a very negative growth in Revenue. The Revenue has been decreasing by -11.72% on average per year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%

3.2 Future

Based on estimates for the next years, BYL will show a very strong growth in Earnings Per Share. The EPS will grow by 37.54% on average per year.
Based on estimates for the next years, BYL will show a decrease in Revenue. The Revenue will decrease by -4.34% on average per year.
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYL.CA Yearly Revenue VS EstimatesBYL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BYL.CA Yearly EPS VS EstimatesBYL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BYL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BYL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL.CA Price Earnings VS Forward Price EarningsBYL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYL.CA Per share dataBYL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as BYL's earnings are expected to grow with 37.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.54%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BYL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYLIN TECHNOLOGIES INC

TSX:BYL (2/18/2025, 7:00:00 PM)

0.3

-0.02 (-4.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-06 2025-03-06
Inst Owners0.56%
Inst Owner ChangeN/A
Ins Owners1.72%
Ins Owner ChangeN/A
Market Cap45.43M
Analysts47.5
Price Target0.51 (70%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.51%
Min EPS beat(2)-98.02%
Max EPS beat(2)67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.72%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)9.63%
Revenue beat(4)2
Avg Revenue beat(4)39.02%
Min Revenue beat(4)-26.46%
Max Revenue beat(4)177.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)66.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)17.75%
Revenue NQ rev (3m)-29.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.9
BVpS-0.04
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.42%
FCFM N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
F-Score4
Asset Turnover2.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.14%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.55
Altman-Z -3.04
F-Score4
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)13.85%
Cap/Depr(5y)37.3%
Cap/Sales(3y)1.29%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.19%
OCF growth 3YN/A
OCF growth 5YN/A